Dissecting the Role of Acetaldehyde in Oral Carcinogenesis
Summary
This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash and cheek brush, and urine. The collection of two blood samples (5 mL each) will be optional and banked for future use.
Arms & interventions
- DrugAlcohol
Alcohol dose given orally that will result in a 0.03% blood alcohol concentration (BAC).
- ProcedureBiospecimen Collection
Undergo saliva, mouthwash, and cheek brush collection
- ProcedureBreath Test
Undergo breathalyzer testing
Outcome measures
Primary
Determine the acetaldehyde exposure to the oral cavity by comparing saliva levels before and after alcohol dose
Identify and quantify DNA adducts in the oral cells (mouthwash and cheek brush samples).
Time frame: Prior to alcohol dose, and 30 minutes, 1 hour, 2 hours, 4 hours, and 6 hours post alcohol dose
Secondary
Urine will be analyzed to confirm non-smoking status
Time frame: Prior to alcohol exposure
Urine will be analyzed to confirm non-smoking status
Time frame: Up to 6 hours after alcohol exposure
Eligibility criteria
Study locations (1)
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, 55455